Awarded contract

Published

NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections

6 suppliers have saved this notice.

Looks like a fit? Save this tender and qualify it in Stotles

Value

1,532,303.9 GBP

Current supplier

Novartis Pharmaceutical UK Ltd

Description

Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025. Lot 1: Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.

Unlock decision maker contacts.

Never miss a tender again

Get alerts, AI summaries and tools to qualify faster

Explore similar pre-tenders, open or awarded contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

NHS National Services Scotland

20,671,084

Published 7 days ago

NHS National Services Scotland

20,671,084

Published 7 days ago

NHS National Services Scotland

8,493,876 GBP

Published 12 days ago

NHS National Services Scotland

8,493,876 GBP

Published 12 days ago

Leeds Teaching Hospitals NHS Trust

19,000,000 GBP

Published 18 days ago

NHS National Services Scotland

1,553,548 GBP

Published a month ago

NHS National Services Scotland

2,625,907 GBP

Published a month ago

NHS National Services Scotland

2,625,907 GBP

Published a month ago

NHS National Services Scotland

1,553,548 GBP

Published a month ago

Sign up to the Stotles Tender Tracker for free

Find even more contracts with advanced search capability and AI powered relevance scoring.